chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Angiogram pulmonary abnormal, Anticoagulant therapy, Asthenia
Clinical narrative: Patient is a 68 y.o. female patient of DO with history of DVT/PE, Hypertension, CVA, Afib who presented to hospital in trasnsfer from different Hospital for further management of COVID 19, acute HFrEF, recurrent PE, acute respiratory failure   Acute Hypoxemic Respiratory Failure Etiology: covid-19, CHF, PE Baseline O2 requirements: room air Current O2 requirements: room air Continue pulmonary hygiene- IS q 1hr Wean O2 to baseline oxygen requirements as able Continue treatment of underlying etiologies as outlined Resolved 1/1   COVID-19 Virus Infection  Date of onset of symptoms: 12/23/2022 Symptoms present on admission: fatigue and generalized weakness  Date of covid positive test: 12/29/2022 Vaccination status: vaccinated Imaging: CTPA 12/28 motion artifact/no evidence of PNA  Oxygen requirements on admission: RA  Current oxygen requirements: 2L/intermittent Medical therapy: decadron, remdesivir Consultants following: None  Anticipated special isolation end date: ~ 01/02/2022   Acute on Chronic HFrEF  TTE 12/2022 with EF 30% Suspect tachycardia mediated > ischemic Continue carvedilol 25mg BID Further GDMT as able, noting cost limitations BN elevated but euvolemic on exam Start lisinopril 10mg daily  Monitor renal function   Paroxysmal AFib with RVR   Intermittent with home Coreg 25 mg BID Cardizem gtt initially, converted to dilt 120mg PO daily  Cardio cs'd Cardizem CD dose increased HR and BP stable Acute pulmonary embolism, recurrent   (12/28) intermittent RVR, tachypnea, and borderline normal SpO2 at rest D dimer 7.44  CT PE thrombus distal right main pulmonary artery extending into the right upper, right middle lobe and right lower lobe pulmonary arterial branches Due to decreased mobility and non compliance with warfarin  Continue Lovenox bridge to theraputic warfarin  Verified with patient's daughter no rx coverage discussed charitable pharmacy and if approved patient can transition to Eliquis at no cost  Family to pick up information and establish telephone appointment to determine eligibility  Per cardio- no indication for thrombectomy INR therapeutic on coumadin 1/1   AKI Resolved   H/o CVA  Residual left sided deficits  Discontinued simvastatin due to risk of rhabdomyolysis with Cardizem  Continue atorvastatin  AC as above    Essential hypertension  Holding home amlodipine and lisinopril  Resume carvedilol  Titrate as able BP stable   Frost bite Blisters noted to left thumb and right index finger  Monitor    Generalized weakness  2 day history PTA  Prior CVA with residual left sided deficits, no new focal deficits  Prior plan of home with home health PT/OT - 2-3 days   Morbid obesity BMI 41.27 kg, adult  Recommend lifestyle modifications    Lung nodule 12 mo follow up CT recommended
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Brain natriuretic peptide increased, COVID-19, Cardiac failure, Cardiac failure acute
Clinical narrative: Patient is a 68 y.o. female patient of DO with history of DVT/PE, Hypertension, CVA, Afib who presented to hospital in trasnsfer from different Hospital for further management of COVID 19, acute HFrEF, recurrent PE, acute respiratory failure   Acute Hypoxemic Respiratory Failure Etiology: covid-19, CHF, PE Baseline O2 requirements: room air Current O2 requirements: room air Continue pulmonary hygiene- IS q 1hr Wean O2 to baseline oxygen requirements as able Continue treatment of underlying etiologies as outlined Resolved 1/1   COVID-19 Virus Infection  Date of onset of symptoms: 12/23/2022 Symptoms present on admission: fatigue and generalized weakness  Date of covid positive test: 12/29/2022 Vaccination status: vaccinated Imaging: CTPA 12/28 motion artifact/no evidence of PNA  Oxygen requirements on admission: RA  Current oxygen requirements: 2L/intermittent Medical therapy: decadron, remdesivir Consultants following: None  Anticipated special isolation end date: ~ 01/02/2022   Acute on Chronic HFrEF  TTE 12/2022 with EF 30% Suspect tachycardia mediated > ischemic Continue carvedilol 25mg BID Further GDMT as able, noting cost limitations BN elevated but euvolemic on exam Start lisinopril 10mg daily  Monitor renal function   Paroxysmal AFib with RVR   Intermittent with home Coreg 25 mg BID Cardizem gtt initially, converted to dilt 120mg PO daily  Cardio cs'd Cardizem CD dose increased HR and BP stable Acute pulmonary embolism, recurrent   (12/28) intermittent RVR, tachypnea, and borderline normal SpO2 at rest D dimer 7.44  CT PE thrombus distal right main pulmonary artery extending into the right upper, right middle lobe and right lower lobe pulmonary arterial branches Due to decreased mobility and non compliance with warfarin  Continue Lovenox bridge to theraputic warfarin  Verified with patient's daughter no rx coverage discussed charitable pharmacy and if approved patient can transition to Eliquis at no cost  Family to pick up information and establish telephone appointment to determine eligibility  Per cardio- no indication for thrombectomy INR therapeutic on coumadin 1/1   AKI Resolved   H/o CVA  Residual left sided deficits  Discontinued simvastatin due to risk of rhabdomyolysis with Cardizem  Continue atorvastatin  AC as above    Essential hypertension  Holding home amlodipine and lisinopril  Resume carvedilol  Titrate as able BP stable   Frost bite Blisters noted to left thumb and right index finger  Monitor    Generalized weakness  2 day history PTA  Prior CVA with residual left sided deficits, no new focal deficits  Prior plan of home with home health PT/OT - 2-3 days   Morbid obesity BMI 41.27 kg, adult  Recommend lifestyle modifications    Lung nodule 12 mo follow up CT recommended
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Computerised tomogram thorax abnormal, Echocardiogram, Fatigue, Fibrin D dimer increased
Clinical narrative: Patient is a 68 y.o. female patient of DO with history of DVT/PE, Hypertension, CVA, Afib who presented to hospital in trasnsfer from different Hospital for further management of COVID 19, acute HFrEF, recurrent PE, acute respiratory failure   Acute Hypoxemic Respiratory Failure Etiology: covid-19, CHF, PE Baseline O2 requirements: room air Current O2 requirements: room air Continue pulmonary hygiene- IS q 1hr Wean O2 to baseline oxygen requirements as able Continue treatment of underlying etiologies as outlined Resolved 1/1   COVID-19 Virus Infection  Date of onset of symptoms: 12/23/2022 Symptoms present on admission: fatigue and generalized weakness  Date of covid positive test: 12/29/2022 Vaccination status: vaccinated Imaging: CTPA 12/28 motion artifact/no evidence of PNA  Oxygen requirements on admission: RA  Current oxygen requirements: 2L/intermittent Medical therapy: decadron, remdesivir Consultants following: None  Anticipated special isolation end date: ~ 01/02/2022   Acute on Chronic HFrEF  TTE 12/2022 with EF 30% Suspect tachycardia mediated > ischemic Continue carvedilol 25mg BID Further GDMT as able, noting cost limitations BN elevated but euvolemic on exam Start lisinopril 10mg daily  Monitor renal function   Paroxysmal AFib with RVR   Intermittent with home Coreg 25 mg BID Cardizem gtt initially, converted to dilt 120mg PO daily  Cardio cs'd Cardizem CD dose increased HR and BP stable Acute pulmonary embolism, recurrent   (12/28) intermittent RVR, tachypnea, and borderline normal SpO2 at rest D dimer 7.44  CT PE thrombus distal right main pulmonary artery extending into the right upper, right middle lobe and right lower lobe pulmonary arterial branches Due to decreased mobility and non compliance with warfarin  Continue Lovenox bridge to theraputic warfarin  Verified with patient's daughter no rx coverage discussed charitable pharmacy and if approved patient can transition to Eliquis at no cost  Family to pick up information and establish telephone appointment to determine eligibility  Per cardio- no indication for thrombectomy INR therapeutic on coumadin 1/1   AKI Resolved   H/o CVA  Residual left sided deficits  Discontinued simvastatin due to risk of rhabdomyolysis with Cardizem  Continue atorvastatin  AC as above    Essential hypertension  Holding home amlodipine and lisinopril  Resume carvedilol  Titrate as able BP stable   Frost bite Blisters noted to left thumb and right index finger  Monitor    Generalized weakness  2 day history PTA  Prior CVA with residual left sided deficits, no new focal deficits  Prior plan of home with home health PT/OT - 2-3 days   Morbid obesity BMI 41.27 kg, adult  Recommend lifestyle modifications    Lung nodule 12 mo follow up CT recommended
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Frostbite, International normalised ratio, Mobility decreased, Pulmonary artery thrombosis, Pulmonary embolism
Clinical narrative: Patient is a 68 y.o. female patient of DO with history of DVT/PE, Hypertension, CVA, Afib who presented to hospital in trasnsfer from different Hospital for further management of COVID 19, acute HFrEF, recurrent PE, acute respiratory failure   Acute Hypoxemic Respiratory Failure Etiology: covid-19, CHF, PE Baseline O2 requirements: room air Current O2 requirements: room air Continue pulmonary hygiene- IS q 1hr Wean O2 to baseline oxygen requirements as able Continue treatment of underlying etiologies as outlined Resolved 1/1   COVID-19 Virus Infection  Date of onset of symptoms: 12/23/2022 Symptoms present on admission: fatigue and generalized weakness  Date of covid positive test: 12/29/2022 Vaccination status: vaccinated Imaging: CTPA 12/28 motion artifact/no evidence of PNA  Oxygen requirements on admission: RA  Current oxygen requirements: 2L/intermittent Medical therapy: decadron, remdesivir Consultants following: None  Anticipated special isolation end date: ~ 01/02/2022   Acute on Chronic HFrEF  TTE 12/2022 with EF 30% Suspect tachycardia mediated > ischemic Continue carvedilol 25mg BID Further GDMT as able, noting cost limitations BN elevated but euvolemic on exam Start lisinopril 10mg daily  Monitor renal function   Paroxysmal AFib with RVR   Intermittent with home Coreg 25 mg BID Cardizem gtt initially, converted to dilt 120mg PO daily  Cardio cs'd Cardizem CD dose increased HR and BP stable Acute pulmonary embolism, recurrent   (12/28) intermittent RVR, tachypnea, and borderline normal SpO2 at rest D dimer 7.44  CT PE thrombus distal right main pulmonary artery extending into the right upper, right middle lobe and right lower lobe pulmonary arterial branches Due to decreased mobility and non compliance with warfarin  Continue Lovenox bridge to theraputic warfarin  Verified with patient's daughter no rx coverage discussed charitable pharmacy and if approved patient can transition to Eliquis at no cost  Family to pick up information and establish telephone appointment to determine eligibility  Per cardio- no indication for thrombectomy INR therapeutic on coumadin 1/1   AKI Resolved   H/o CVA  Residual left sided deficits  Discontinued simvastatin due to risk of rhabdomyolysis with Cardizem  Continue atorvastatin  AC as above    Essential hypertension  Holding home amlodipine and lisinopril  Resume carvedilol  Titrate as able BP stable   Frost bite Blisters noted to left thumb and right index finger  Monitor    Generalized weakness  2 day history PTA  Prior CVA with residual left sided deficits, no new focal deficits  Prior plan of home with home health PT/OT - 2-3 days   Morbid obesity BMI 41.27 kg, adult  Recommend lifestyle modifications    Lung nodule 12 mo follow up CT recommended
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary mass, SARS-CoV-2 test positive, Tachycardia, Tachypnoea, Treatment noncompliance
Clinical narrative: Patient is a 68 y.o. female patient of DO with history of DVT/PE, Hypertension, CVA, Afib who presented to hospital in trasnsfer from different Hospital for further management of COVID 19, acute HFrEF, recurrent PE, acute respiratory failure   Acute Hypoxemic Respiratory Failure Etiology: covid-19, CHF, PE Baseline O2 requirements: room air Current O2 requirements: room air Continue pulmonary hygiene- IS q 1hr Wean O2 to baseline oxygen requirements as able Continue treatment of underlying etiologies as outlined Resolved 1/1   COVID-19 Virus Infection  Date of onset of symptoms: 12/23/2022 Symptoms present on admission: fatigue and generalized weakness  Date of covid positive test: 12/29/2022 Vaccination status: vaccinated Imaging: CTPA 12/28 motion artifact/no evidence of PNA  Oxygen requirements on admission: RA  Current oxygen requirements: 2L/intermittent Medical therapy: decadron, remdesivir Consultants following: None  Anticipated special isolation end date: ~ 01/02/2022   Acute on Chronic HFrEF  TTE 12/2022 with EF 30% Suspect tachycardia mediated > ischemic Continue carvedilol 25mg BID Further GDMT as able, noting cost limitations BN elevated but euvolemic on exam Start lisinopril 10mg daily  Monitor renal function   Paroxysmal AFib with RVR   Intermittent with home Coreg 25 mg BID Cardizem gtt initially, converted to dilt 120mg PO daily  Cardio cs'd Cardizem CD dose increased HR and BP stable Acute pulmonary embolism, recurrent   (12/28) intermittent RVR, tachypnea, and borderline normal SpO2 at rest D dimer 7.44  CT PE thrombus distal right main pulmonary artery extending into the right upper, right middle lobe and right lower lobe pulmonary arterial branches Due to decreased mobility and non compliance with warfarin  Continue Lovenox bridge to theraputic warfarin  Verified with patient's daughter no rx coverage discussed charitable pharmacy and if approved patient can transition to Eliquis at no cost  Family to pick up information and establish telephone appointment to determine eligibility  Per cardio- no indication for thrombectomy INR therapeutic on coumadin 1/1   AKI Resolved   H/o CVA  Residual left sided deficits  Discontinued simvastatin due to risk of rhabdomyolysis with Cardizem  Continue atorvastatin  AC as above    Essential hypertension  Holding home amlodipine and lisinopril  Resume carvedilol  Titrate as able BP stable   Frost bite Blisters noted to left thumb and right index finger  Monitor    Generalized weakness  2 day history PTA  Prior CVA with residual left sided deficits, no new focal deficits  Prior plan of home with home health PT/OT - 2-3 days   Morbid obesity BMI 41.27 kg, adult  Recommend lifestyle modifications    Lung nodule 12 mo follow up CT recommended
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated
Age: 93.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Thermal burn
Clinical narrative: hospitalized with covid; fully vaccinated with 3 boosters
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Fall, Magnetic resonance imaging spinal normal, Muscular weakness
Clinical narrative: Patient is a 81 y.o. male admitted to the hospital on 12/28/2022 for weakness and falls at independent living. He tested positive for COVID and was having increased weakness of the legs thus MRI lumbar spine was performed; no acute findings were noted. He will follow-up with neurosurgery; he will be discharged.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient is a 81 y.o. male admitted to the hospital on 12/28/2022 for weakness and falls at independent living. He tested positive for COVID and was having increased weakness of the legs thus MRI lumbar spine was performed; no acute findings were noted. He will follow-up with neurosurgery; he will be discharged.
Age: 55.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Bloody discharge, Diarrhoea, Fatigue, Full blood count, Influenza virus test negative
Clinical narrative: Migraine for 4 days FATIGUE, body aches, nausea, diarrhea, one day very bloody discharge but not BM.
Age: 55.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Metabolic function test, Migraine, Nausea, Pain, SARS-CoV-2 test negative
Clinical narrative: Migraine for 4 days FATIGUE, body aches, nausea, diarrhea, one day very bloody discharge but not BM.
Age: 55.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Diarrhoea, Fatigue, Migraine, Myalgia, Nausea
Clinical narrative: Migraine for 4 days FATIGUE, body aches, nausea, diarrhea, one day very bloody discharge but not BM.
Age: 55.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Rectal haemorrhage, Viral infection, Vomiting, Weight
Clinical narrative: Migraine for 4 days FATIGUE, body aches, nausea, diarrhea, one day very bloody discharge but not BM.
Age: 93.0
Sex: F
Vaccine: COVID19-2
Symptoms: Atrial fibrillation, COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with 3 boosters
Age: 55.0
Sex: M
Vaccine: COVID19-2
Symptoms: Biopsy, Blood test normal, Cardiac stress test normal, Chest pain, Echocardiogram normal
Clinical narrative: On 10/22/2022, three days after receiving my vaccine, I started experiencing substernal chest pain. About a four or five out of ten. The next morning, I went to work and was experiencing heart palpitations with the same degree of chest pain. I had a colleague check my blood pressure and it was high, so I went to the emergency department. They evaluated an EKG and ran some blood tests to look for a heart attack. They didn't find any evidence of that, so they felt that it was probably a gastrointestinal issue and placed me on some medications to take and advised that I follow up with my physician. I started taking the medications, but the pain continued. About three days later, I went to my primary care office and saw a cardiologist. He sent me for an echocardiogram to evaluate my heart and scheduled me for a stress test. Throughout this time, I continued taking the medication that was prescribed at the emergency department and was waiting for an appointment with a gastroenterologist. I was notified by my primary care physician that all the cardio tests were normal. The gastroenterologist did an upper and lower endoscopy in December. She felt that she saw evidence of a condition called Eosinophilic Esophagitis. She changed my medication and the symptoms have subsided over time. I have another follow up with a gastroenterologist in March.
Age: 55.0
Sex: M
Vaccine: COVID19-2
Symptoms: Electrocardiogram normal, Endoscopy gastrointestinal abnormal, Eosinophilic oesophagitis, Hypertension, Palpitations
Clinical narrative: On 10/22/2022, three days after receiving my vaccine, I started experiencing substernal chest pain. About a four or five out of ten. The next morning, I went to work and was experiencing heart palpitations with the same degree of chest pain. I had a colleague check my blood pressure and it was high, so I went to the emergency department. They evaluated an EKG and ran some blood tests to look for a heart attack. They didn't find any evidence of that, so they felt that it was probably a gastrointestinal issue and placed me on some medications to take and advised that I follow up with my physician. I started taking the medications, but the pain continued. About three days later, I went to my primary care office and saw a cardiologist. He sent me for an echocardiogram to evaluate my heart and scheduled me for a stress test. Throughout this time, I continued taking the medication that was prescribed at the emergency department and was waiting for an appointment with a gastroenterologist. I was notified by my primary care physician that all the cardio tests were normal. The gastroenterologist did an upper and lower endoscopy in December. She felt that she saw evidence of a condition called Eosinophilic Esophagitis. She changed my medication and the symptoms have subsided over time. I have another follow up with a gastroenterologist in March.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Anxiety, Blood culture negative, Blood lactic acid normal
Clinical narrative: patient is a 65 y.o. female patient of  MD with history of Coronary artery disease, hypertension, hyperlipidemia, and asthma, now presented to a local Hospital with pneumonia.   COVID 19 pneumonia   Acute hypoxemic respiratory failure d/t above  Sepsis, POA, d/t above and below  Lactic acid within normal limits, no need for IVF resuscitation WBC 29K CTPA: negative PE.  MF pneumonia noted. Bronchial wall thickening present as well  Blood and urine cultures NGTD.  Strep & legionella negative Continue remdesivir, and decadron.  Will increase decadron to 10mg daily.  Discontinue levaquin given negative procal and imaging suggestive of viral pna  Suspect leukocytosis d/t steroid administration  MRSA swab negative. PCT negative, discontinue abx.   CRP markedly elevated and improving.  Resume home lasix  Stable on 4-5L NC with ambulation.   Ready for discharge home to complete steroid therapy  RX for ativan PRN for anxiety sent to pharmacy    hypertension  Initially low normal, now elevated.  Resume home lisinopril and coreg.   prescribed 40mg BID of lisinopril which is inappropriate.  Change to daily   Resume home lasix  Continue nifedipine daily on discharge.    hyperlipidemia Continue home pravastatin.   Cigarette dependence without complication Counseled on cessation for 3-10 minutes.   Will write for tobacco replacement patch.   Solitary pulmonary nodule Incidental finding in the right upper lobe on admission CT chest. Outpatient surveillance imaging at discretion of family physician after resolution of acute presenting issues.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchial wall thickening, C-reactive protein increased, COVID-19 pneumonia, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: patient is a 65 y.o. female patient of  MD with history of Coronary artery disease, hypertension, hyperlipidemia, and asthma, now presented to a local Hospital with pneumonia.   COVID 19 pneumonia   Acute hypoxemic respiratory failure d/t above  Sepsis, POA, d/t above and below  Lactic acid within normal limits, no need for IVF resuscitation WBC 29K CTPA: negative PE.  MF pneumonia noted. Bronchial wall thickening present as well  Blood and urine cultures NGTD.  Strep & legionella negative Continue remdesivir, and decadron.  Will increase decadron to 10mg daily.  Discontinue levaquin given negative procal and imaging suggestive of viral pna  Suspect leukocytosis d/t steroid administration  MRSA swab negative. PCT negative, discontinue abx.   CRP markedly elevated and improving.  Resume home lasix  Stable on 4-5L NC with ambulation.   Ready for discharge home to complete steroid therapy  RX for ativan PRN for anxiety sent to pharmacy    hypertension  Initially low normal, now elevated.  Resume home lisinopril and coreg.   prescribed 40mg BID of lisinopril which is inappropriate.  Change to daily   Resume home lasix  Continue nifedipine daily on discharge.    hyperlipidemia Continue home pravastatin.   Cigarette dependence without complication Counseled on cessation for 3-10 minutes.   Will write for tobacco replacement patch.   Solitary pulmonary nodule Incidental finding in the right upper lobe on admission CT chest. Outpatient surveillance imaging at discretion of family physician after resolution of acute presenting issues.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Culture urine negative, Hypertension, Legionella test, Leukocytosis, Pneumonia
Clinical narrative: patient is a 65 y.o. female patient of  MD with history of Coronary artery disease, hypertension, hyperlipidemia, and asthma, now presented to a local Hospital with pneumonia.   COVID 19 pneumonia   Acute hypoxemic respiratory failure d/t above  Sepsis, POA, d/t above and below  Lactic acid within normal limits, no need for IVF resuscitation WBC 29K CTPA: negative PE.  MF pneumonia noted. Bronchial wall thickening present as well  Blood and urine cultures NGTD.  Strep & legionella negative Continue remdesivir, and decadron.  Will increase decadron to 10mg daily.  Discontinue levaquin given negative procal and imaging suggestive of viral pna  Suspect leukocytosis d/t steroid administration  MRSA swab negative. PCT negative, discontinue abx.   CRP markedly elevated and improving.  Resume home lasix  Stable on 4-5L NC with ambulation.   Ready for discharge home to complete steroid therapy  RX for ativan PRN for anxiety sent to pharmacy    hypertension  Initially low normal, now elevated.  Resume home lisinopril and coreg.   prescribed 40mg BID of lisinopril which is inappropriate.  Change to daily   Resume home lasix  Continue nifedipine daily on discharge.    hyperlipidemia Continue home pravastatin.   Cigarette dependence without complication Counseled on cessation for 3-10 minutes.   Will write for tobacco replacement patch.   Solitary pulmonary nodule Incidental finding in the right upper lobe on admission CT chest. Outpatient surveillance imaging at discretion of family physician after resolution of acute presenting issues.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia viral, Procalcitonin normal, Pulmonary mass, Sepsis, Staphylococcus test negative
Clinical narrative: patient is a 65 y.o. female patient of  MD with history of Coronary artery disease, hypertension, hyperlipidemia, and asthma, now presented to a local Hospital with pneumonia.   COVID 19 pneumonia   Acute hypoxemic respiratory failure d/t above  Sepsis, POA, d/t above and below  Lactic acid within normal limits, no need for IVF resuscitation WBC 29K CTPA: negative PE.  MF pneumonia noted. Bronchial wall thickening present as well  Blood and urine cultures NGTD.  Strep & legionella negative Continue remdesivir, and decadron.  Will increase decadron to 10mg daily.  Discontinue levaquin given negative procal and imaging suggestive of viral pna  Suspect leukocytosis d/t steroid administration  MRSA swab negative. PCT negative, discontinue abx.   CRP markedly elevated and improving.  Resume home lasix  Stable on 4-5L NC with ambulation.   Ready for discharge home to complete steroid therapy  RX for ativan PRN for anxiety sent to pharmacy    hypertension  Initially low normal, now elevated.  Resume home lisinopril and coreg.   prescribed 40mg BID of lisinopril which is inappropriate.  Change to daily   Resume home lasix  Continue nifedipine daily on discharge.    hyperlipidemia Continue home pravastatin.   Cigarette dependence without complication Counseled on cessation for 3-10 minutes.   Will write for tobacco replacement patch.   Solitary pulmonary nodule Incidental finding in the right upper lobe on admission CT chest. Outpatient surveillance imaging at discretion of family physician after resolution of acute presenting issues.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Streptococcus test negative, White blood cell count increased
Clinical narrative: patient is a 65 y.o. female patient of  MD with history of Coronary artery disease, hypertension, hyperlipidemia, and asthma, now presented to a local Hospital with pneumonia.   COVID 19 pneumonia   Acute hypoxemic respiratory failure d/t above  Sepsis, POA, d/t above and below  Lactic acid within normal limits, no need for IVF resuscitation WBC 29K CTPA: negative PE.  MF pneumonia noted. Bronchial wall thickening present as well  Blood and urine cultures NGTD.  Strep & legionella negative Continue remdesivir, and decadron.  Will increase decadron to 10mg daily.  Discontinue levaquin given negative procal and imaging suggestive of viral pna  Suspect leukocytosis d/t steroid administration  MRSA swab negative. PCT negative, discontinue abx.   CRP markedly elevated and improving.  Resume home lasix  Stable on 4-5L NC with ambulation.   Ready for discharge home to complete steroid therapy  RX for ativan PRN for anxiety sent to pharmacy    hypertension  Initially low normal, now elevated.  Resume home lisinopril and coreg.   prescribed 40mg BID of lisinopril which is inappropriate.  Change to daily   Resume home lasix  Continue nifedipine daily on discharge.    hyperlipidemia Continue home pravastatin.   Cigarette dependence without complication Counseled on cessation for 3-10 minutes.   Will write for tobacco replacement patch.   Solitary pulmonary nodule Incidental finding in the right upper lobe on admission CT chest. Outpatient surveillance imaging at discretion of family physician after resolution of acute presenting issues.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain
Clinical narrative: After receiving the vaccine, I had intermittent pain but the next day it was constant. The pain is on the right side and is a radiating pain. It progresses all day long. I have been to my doctor and to a pain management doctor. I am at a point of trying to figure out what is going on.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated
Sex: M
Vaccine: HEP
Symptoms: Expired product administered
Clinical narrative: Expired 12/22/22 Hep B given to patient on 1/12/23
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium normal, COVID-19, Chest X-ray normal, Dehydration, Device occlusion
Clinical narrative: The patient is a 46 y.o. male with history of brain tumor, feeding tube, PEG dependence presented to Hospital with nausea and hematemesis.   Covid-19 Virus Infection Date of onset of symptoms: 12/22/22 Symptoms present on admission: Malaise, nausea, and vomiting Date of covid positive test: 12/25/22 Vaccination status: vaccinated Imaging: CXR clear Oxygen requirements on admission: room air Current oxygen requirements: room air Medical therapy: not indicated   Hematemesis Nausea and Vomiting (resolved) Possible acute GI bleeding Hgb 15.3 at sending facility,  Hgb 13.1 (12/27) No known history or risk factors for varices Continue BID IV Protonix Continue NPO General surgery consult-see below Check guaiac here Type and screen CTA at sending facility nonacute, but essentially useless for assessment of GI bleeding because he had PEG placement confirmed using enteral contrast prior to CTA Start scopolamine and continue PRN Zofran, can add additional if needed Start D5, 0.45% normal saline with 20 mEq potassium chloride as maintenance fluid   PEG tube malfunction Placement and function confirmed with contrast injection at sending facility General surgery consult-PEG tube likely causing obstruction at pylorus and was pulled back.  Have discussed with general surgery and this is likely cause of patient's nausea and vomiting which is now resolved Keep PEG tube at 2 cm depth, secured on skin with stat lock Dietician consulted- Resume tube feed, can use patient's home regimen/formula Tube feed continued without incident and no nausea or vomiting   History of brain tumor s/p resection History of stroke Continue seizure prophylaxis, convert Keppra and Phenytoin to IV while vomiting Craniotomy, aphasia and LUE deficits noted on admission, all at reported baseline Resume Aricept as able in cognitive deficit ASA held for stroke prophylaxis in setting of GI bleeding as above  Hyponatremia (resolved) Sodium 134 at sending facility Suspect secondary to dehydration IV fluids Sodium 138 (12/28)  Hypokalemia, POA (resolved)  Moderate Likely secondary to persistent vomiting Potassium lowest at 2.7 (12/26) Potassium 3.8 (12/28)
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Gastrointestinal haemorrhage, Haematemesis, Haemoglobin decreased, Malaise, Nausea
Clinical narrative: The patient is a 46 y.o. male with history of brain tumor, feeding tube, PEG dependence presented to Hospital with nausea and hematemesis.   Covid-19 Virus Infection Date of onset of symptoms: 12/22/22 Symptoms present on admission: Malaise, nausea, and vomiting Date of covid positive test: 12/25/22 Vaccination status: vaccinated Imaging: CXR clear Oxygen requirements on admission: room air Current oxygen requirements: room air Medical therapy: not indicated   Hematemesis Nausea and Vomiting (resolved) Possible acute GI bleeding Hgb 15.3 at sending facility,  Hgb 13.1 (12/27) No known history or risk factors for varices Continue BID IV Protonix Continue NPO General surgery consult-see below Check guaiac here Type and screen CTA at sending facility nonacute, but essentially useless for assessment of GI bleeding because he had PEG placement confirmed using enteral contrast prior to CTA Start scopolamine and continue PRN Zofran, can add additional if needed Start D5, 0.45% normal saline with 20 mEq potassium chloride as maintenance fluid   PEG tube malfunction Placement and function confirmed with contrast injection at sending facility General surgery consult-PEG tube likely causing obstruction at pylorus and was pulled back.  Have discussed with general surgery and this is likely cause of patient's nausea and vomiting which is now resolved Keep PEG tube at 2 cm depth, secured on skin with stat lock Dietician consulted- Resume tube feed, can use patient's home regimen/formula Tube feed continued without incident and no nausea or vomiting   History of brain tumor s/p resection History of stroke Continue seizure prophylaxis, convert Keppra and Phenytoin to IV while vomiting Craniotomy, aphasia and LUE deficits noted on admission, all at reported baseline Resume Aricept as able in cognitive deficit ASA held for stroke prophylaxis in setting of GI bleeding as above  Hyponatremia (resolved) Sodium 134 at sending facility Suspect secondary to dehydration IV fluids Sodium 138 (12/28)  Hypokalemia, POA (resolved)  Moderate Likely secondary to persistent vomiting Potassium lowest at 2.7 (12/26) Potassium 3.8 (12/28)
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Obstruction gastric, SARS-CoV-2 test positive, Vomiting
Clinical narrative: The patient is a 46 y.o. male with history of brain tumor, feeding tube, PEG dependence presented to Hospital with nausea and hematemesis.   Covid-19 Virus Infection Date of onset of symptoms: 12/22/22 Symptoms present on admission: Malaise, nausea, and vomiting Date of covid positive test: 12/25/22 Vaccination status: vaccinated Imaging: CXR clear Oxygen requirements on admission: room air Current oxygen requirements: room air Medical therapy: not indicated   Hematemesis Nausea and Vomiting (resolved) Possible acute GI bleeding Hgb 15.3 at sending facility,  Hgb 13.1 (12/27) No known history or risk factors for varices Continue BID IV Protonix Continue NPO General surgery consult-see below Check guaiac here Type and screen CTA at sending facility nonacute, but essentially useless for assessment of GI bleeding because he had PEG placement confirmed using enteral contrast prior to CTA Start scopolamine and continue PRN Zofran, can add additional if needed Start D5, 0.45% normal saline with 20 mEq potassium chloride as maintenance fluid   PEG tube malfunction Placement and function confirmed with contrast injection at sending facility General surgery consult-PEG tube likely causing obstruction at pylorus and was pulled back.  Have discussed with general surgery and this is likely cause of patient's nausea and vomiting which is now resolved Keep PEG tube at 2 cm depth, secured on skin with stat lock Dietician consulted- Resume tube feed, can use patient's home regimen/formula Tube feed continued without incident and no nausea or vomiting   History of brain tumor s/p resection History of stroke Continue seizure prophylaxis, convert Keppra and Phenytoin to IV while vomiting Craniotomy, aphasia and LUE deficits noted on admission, all at reported baseline Resume Aricept as able in cognitive deficit ASA held for stroke prophylaxis in setting of GI bleeding as above  Hyponatremia (resolved) Sodium 134 at sending facility Suspect secondary to dehydration IV fluids Sodium 138 (12/28)  Hypokalemia, POA (resolved)  Moderate Likely secondary to persistent vomiting Potassium lowest at 2.7 (12/26) Potassium 3.8 (12/28)
Age: 67.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Otitis media, SARS-CoV-2 test negative, Sinonasal obstruction
Clinical narrative: I had blockage or fluid in my right ear, I saw my doctor on 12/09/2022. I had no fever but I had sinus blockage on my right side as well. Doctor noted amber fluid noted behind right ear.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Blood test, Computerised tomogram thorax abnormal, Dyspnoea exertional, Dysstasia, Exercise tolerance decreased
Clinical narrative: I began having symptoms November 30th which included quickly becoming out of breath with a small amount of exercise and faster heart rate. Symptoms presented again that weekend (fast heart rate, out of breath, easily tired with minimal exercise). Beginning Decemeber 2nd I had glute and leg pain which I thought was Sciatic pain. I went to see my PCP office Dec 9th and ended up in the ER a few hours later due to left leg swelling to the point of barely being able to stand on it and pain. I was diagnosed with DVT from common femoral to common iliac and bilateral Pulmonary Embolism. I am an avid runner, cyclist, walker, and I eat healthier and stay better hydrated than average. Cause is unknown at this time, but suggestions were made about birth control that I had been on for 22 years or combination of factors. I have not yet had genetic testing, so may have genetic predisposition. I am reporting solely because of reading other reports where vaccines may contribute toward blood clots. I understand risk of getting clots is higher if I had Covid, but I never had Covid to my knowledge.  No injuries, surgeries, pregnancy, or other typical cause. This seems to be happening to a lot of younger otherwise healthy people.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Fatigue, Heart rate increased, Musculoskeletal pain, Pain in extremity, Pelvic venous thrombosis
Clinical narrative: I began having symptoms November 30th which included quickly becoming out of breath with a small amount of exercise and faster heart rate. Symptoms presented again that weekend (fast heart rate, out of breath, easily tired with minimal exercise). Beginning Decemeber 2nd I had glute and leg pain which I thought was Sciatic pain. I went to see my PCP office Dec 9th and ended up in the ER a few hours later due to left leg swelling to the point of barely being able to stand on it and pain. I was diagnosed with DVT from common femoral to common iliac and bilateral Pulmonary Embolism. I am an avid runner, cyclist, walker, and I eat healthier and stay better hydrated than average. Cause is unknown at this time, but suggestions were made about birth control that I had been on for 22 years or combination of factors. I have not yet had genetic testing, so may have genetic predisposition. I am reporting solely because of reading other reports where vaccines may contribute toward blood clots. I understand risk of getting clots is higher if I had Covid, but I never had Covid to my knowledge.  No injuries, surgeries, pregnancy, or other typical cause. This seems to be happening to a lot of younger otherwise healthy people.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Pulmonary embolism, Ultrasound Doppler abnormal
Clinical narrative: I began having symptoms November 30th which included quickly becoming out of breath with a small amount of exercise and faster heart rate. Symptoms presented again that weekend (fast heart rate, out of breath, easily tired with minimal exercise). Beginning Decemeber 2nd I had glute and leg pain which I thought was Sciatic pain. I went to see my PCP office Dec 9th and ended up in the ER a few hours later due to left leg swelling to the point of barely being able to stand on it and pain. I was diagnosed with DVT from common femoral to common iliac and bilateral Pulmonary Embolism. I am an avid runner, cyclist, walker, and I eat healthier and stay better hydrated than average. Cause is unknown at this time, but suggestions were made about birth control that I had been on for 22 years or combination of factors. I have not yet had genetic testing, so may have genetic predisposition. I am reporting solely because of reading other reports where vaccines may contribute toward blood clots. I understand risk of getting clots is higher if I had Covid, but I never had Covid to my knowledge.  No injuries, surgeries, pregnancy, or other typical cause. This seems to be happening to a lot of younger otherwise healthy people.
Age: 1.08
Sex: F
Vaccine: FLUC4, HEPA, MMRV, PNC13, VARCEL
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event reported, extra dose of vaccine was administered.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received a second Moderna Bivalent booster.  No adverse reactions during the 15 min observation period. She was made aware that she received an extra unauthorized booster. She was confused because they told her it was time for her to get another booster.
Age: 1.0
Sex: M
Vaccine: MMR, PNC13, VARCEL
Symptoms: Decreased appetite, Insomnia, Irritability, Rash, Rash erythematous
Clinical narrative: Developed a red vesicular rash on right thigh and buttock. He has also been more irritable, not sleeping or eating as well, and had a runny nose.
Age: 1.0
Sex: M
Vaccine: MMR, PNC13, VARCEL
Symptoms: Rash vesicular, Rhinorrhoea, Varicella virus test positive
Clinical narrative: Developed a red vesicular rash on right thigh and buttock. He has also been more irritable, not sleeping or eating as well, and had a runny nose.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ischaemic stroke
Clinical narrative: Ischemic Stroke
Age: 1.08
Sex: F
Vaccine: FLU4, VARCEL
Symptoms: Full blood count abnormal, Granulocyte count, Haematocrit normal, Haemoglobin normal, Hypotonia
Clinical narrative: Mother reported vomiting  Friday 1/6/2023 and Saturday, 1/7/2023; mother reported patient was fine on Sunday, 1/8/2023; mother reported a fever and decreased movement starting  Monday 1/9/2023 office visit - difficulty bearing weight, fever.   Thursday, 1/12/2023:  Lethargic, difficulty bearing weight and hypotonia lower extrementies - remains on antipyretics.
Age: 1.08
Sex: F
Vaccine: FLU4, VARCEL
Symptoms: Influenza A virus test negative, Influenza B virus test, Lethargy, Mean platelet volume decreased, Mobility decreased
Clinical narrative: Mother reported vomiting  Friday 1/6/2023 and Saturday, 1/7/2023; mother reported patient was fine on Sunday, 1/8/2023; mother reported a fever and decreased movement starting  Monday 1/9/2023 office visit - difficulty bearing weight, fever.   Thursday, 1/12/2023:  Lethargic, difficulty bearing weight and hypotonia lower extrementies - remains on antipyretics.
Age: 1.08
Sex: F
Vaccine: FLU4, VARCEL
Symptoms: Pyrexia, Red cell distribution width increased, Vomiting, Weight bearing difficulty
Clinical narrative: Mother reported vomiting  Friday 1/6/2023 and Saturday, 1/7/2023; mother reported patient was fine on Sunday, 1/8/2023; mother reported a fever and decreased movement starting  Monday 1/9/2023 office visit - difficulty bearing weight, fever.   Thursday, 1/12/2023:  Lethargic, difficulty bearing weight and hypotonia lower extrementies - remains on antipyretics.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient came to see PCP on 12/15 for annual checke up. PCP reviewed immunization record, last dose of covid vaccine was given on 04/15/2022 which was monovalent, pt denied any other covid vaccine received afterwards. Then PCP offerred Pfizer Bivalent booster, pt agreed and received on same day, left office w/o any complaint after 15 min observation. Later afternoon, patient called PCP office that he found vaccine record at home which showed he had Moderna Bivalent booster on 10/18/2022 by Pharmacy already. Pt denied any discomfort at that time. Nurse called pt on 12/16  for f/u. Pt reported doing well, denied fever, body aches/chills or any discomfort. No erythema or swelling noted at injection site. Reported
Age: 45.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Arthralgia, Inflammation, Injected limb mobility decreased, Shoulder injury related to vaccine administration, Ultrasound scan abnormal
Clinical narrative: Shoulder injury related to vaccine administration  Severe L shoulder pain developed within hours of vaccination. Symptoms have improved significantly but persist since vaccination. I received a steroid injection in the L shoulder and saw physical therapy for 5 sessions. I do not have normal use of my left arm.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, COVID-19, Fatigue, Headache, Oropharyngeal pain
Clinical narrative: I received my Covid-19 vaccine on 10/19/2022. On 12/27/2022 I woke up with a headache and fatigue.  Next day my headache gotten worse and with a sore throat, congestion and upset stomach. I took a home Covid test and was positive. I contacted my doctor and was prescribed Paxlovid. Symptoms lasted a couple days with ongoing congestion issues.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I received my Covid-19 vaccine on 10/19/2022. On 12/27/2022 I woke up with a headache and fatigue.  Next day my headache gotten worse and with a sore throat, congestion and upset stomach. I took a home Covid test and was positive. I contacted my doctor and was prescribed Paxlovid. Symptoms lasted a couple days with ongoing congestion issues.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given a 7th dose of DTaP by age 4yr.    Patient had history of 2 invalid doses previously.  No adverse outcomes that we are aware of at this time.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Dyspnoea, Influenza virus test negative, Malaise, Musculoskeletal stiffness
Clinical narrative: I had a little stiffness in my arm after receiving the vaccine for about a day.  On 11/28/2022 I began not feeling well with a terrible cough, congestion, terrible sore throat and shortness of breath. I was tested for strep throat, influenza and COVID-19 all was negative.  I was told it was viral infection, but I was given an antibiotic. I took the antibiotic, but it did not help.  I used cough drops for my throat and slept with a humidify.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test negative, Streptococcus test negative, Viral infection
Clinical narrative: I had a little stiffness in my arm after receiving the vaccine for about a day.  On 11/28/2022 I began not feeling well with a terrible cough, congestion, terrible sore throat and shortness of breath. I was tested for strep throat, influenza and COVID-19 all was negative.  I was told it was viral infection, but I was given an antibiotic. I took the antibiotic, but it did not help.  I used cough drops for my throat and slept with a humidify.
Age: 61.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Burning sensation, Herpes zoster, Neuralgia, Rash, Rash erythematous
Clinical narrative: I have been diagnosed with Shingles since having had my COVID-19 vaccine. I noticed this rash that was red and splotchy and tender to the touch. It was on my right hip it then began to get more painful, it was burning, and itchy. It was bothering me enough that I was not sleeping. At first, I thought it may be a bug bite but as it spread and got worse, I reached out to my doctor and went in, and she confirmed what I had found with research and that it was shingles. They gave me an antiviral and some gabapentin to help with the nerve pain since shingles affects the nerves. I have been using calamine lotion which helps but it is still itchy and bothering me. I did have my flu vaccine the same day that I had my COVID-19 shot but I do not have the information on that shot, I also had never had a flu shot prior that day.